Our products and services include:
Pharmacor
Analyzing and Forecasting the Commercial Outlook for Drugs on the Market and in Research and Development
Pharmacor, Decision Resources' flagship advisory service, assesses the overall clinical and commercial environment for drug therapies within a disease indication.
Spectrum
Vital Intelligence for Pharmaceutical and Biotechnology Decision Makers
Spectrum is a comprehensive executive advisory service that identifies and analyzes key business and technology drivers of the pharmaceutical and biotechnology markets.
Brand Perception Series
Measuring Physician and Patient Perspectives of Drug Attributes and Marketing Messages
When your brand reaches the market, you can’t change its clinical profile, but you can change how your brand is perceived. While understanding brand perception is essential for any in-line or soon to launch brand, this task is challenging for market researchers, marketers and brand teams due to the lack of low cost, comprehensive primary research.
Emerging Markets
The Ultimate Analysis of New and Growing Pharmaceutical Markets
Decision Resources is the FIRST and ONLY company to offer a syndicated report series for high-growth emerging markets with comprehensive disease-specific analysis.
DecisionBase
Empowering Decision Makers with Robust Interactive Data and Analysis
DecisionBase is an interactive decision tool that allows you to measure and compare commercial opportunities, compound attributes and treatment protocols.
PatientBase
Customizable Epidemiological Data
PatientBase is a flexible data tool set that you can easily manipulate to create custom epidemiological projections of key patient segments.
Physician & Payer Forum
Primary Market Research at a Multi-Client Price
Physician & Payer Forum includes direct feedback from high-volume-prescribing primary care physicians, viewpoints from the managed care sector and insight into the impact of events on specific markets.
Treatment Algorithms Insight Series
Quantifying Lines of Therapy through Primary Research and Patient-Level Data
Decision Resources combines in-depth primary research with the most extensive claims-based longitudinal patient-level data from IMS LifeLink: Health Plan Claims database to provide exceptional insight into physicians' prescribing trends and the factors that drive therapy product choice, from diagnosis through multiple courses of treatment, for a specific disease.
SAMM
Strategic Assessment of Managed Markets
Strategic Assessment of Managed Markets is the first disease-based report series offering the information needed to build a bottom-up, city-by-city managed care strategy for individual drug brands.
Pharmaview
Invaluable Corporate and Commercial Analysis of the Biopharmaceutical Industry
Pharmaview offers all the insight you need to understand how each player in the biopharmaceutical industry functions. Financial information, individual company breakdown, therapeutic analysis and impact of major events are all contained in a subscription to Pharmaview.
PatientFinder
A Novel Approach to Local Market Sizing
PatientFinder is an online, user-driven, flexible data set that you can easily manipulate to reveal the true disease opportunity at a local market level. This is the only healthcare analytics tool that assesses local markets for expansion opportunity by determining the number of insured patients in each territory who have the disease but are untreated.
Hospital Anti-Infectives Insight Series
Analyzing Hospital Antibiotic Prescribing Patterns and Receptivity to Emerging Agents
AMR and Decision Resources’ Hospital Anti-Infectives Insight Series analyzes hospital antibiotic prescribing patterns using AMR’s comprehensive and highly detailed clinical data in conjunction with Decision Resources’ disease area knowledge, primary research and extensive understanding of emerging therapies and forecasts.
Disease-Specific & Industry Reports
Decision Resources produces more than 150 reports each year. They span a broad array of subjects, ranging from specific diseases or research pathways to analysis of key issues facing the biopharmaceutical industry today.
Consulting & Advisory Services
Decision Resources Consulting group is dedicated to helping pharmaceutical, biotech and other healthcare companies develop true competitive advantage.
Epidemiology & Forecasting
Decision Resources offers the industry’s leading epidemiology and market forecasts for the world’s most significant diseases.